We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

115 hedge funds and large institutions have $377M invested in Spectrum Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 41

1% more capital invested

Capital invested by funds: $374M → $377M (+$3.07M)

3% less funds holding

Funds holding: 118115 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

48% less call options, than puts

Call options by funds: $1.88M | Put options by funds: $3.62M

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
43
Reduced
41
Closed
15
Calls
$1.88M
Puts
$3.62M
Net Calls
-$1.74M
Net Calls Change
-$312K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$53.4M -$1.18M -131,745 -2%
BFA
2
BlackRock Fund Advisors
California
$38.3M +$1.46M +163,150 +4%
Millennium Management
3
Millennium Management
New York
$33.1M +$7.68M +859,671 +30%
Vanguard Group
4
Vanguard Group
Pennsylvania
$32.2M +$2.86M +319,849 +10%
State Street
5
State Street
Massachusetts
$24M -$5.9M -660,871 -20%
DM
6
Deerfield Management
New York
$20.9M -$5.99M -670,345 -22%
FCAM
7
F&C Asset Management
United Kingdom
$16.1M +$1.39M +155,624 +9%
BIT
8
BlackRock Institutional Trust
California
$15.9M -$75.3K -8,431 -0.5%
Goldman Sachs
9
Goldman Sachs
New York
$11.7M +$501K +56,050 +4%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$11.1M -$137K -15,330 -1%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$10.4M +$10.4M +1,162,749 +11,280%
KCM
12
Kennedy Capital Management
Missouri
$8.27M -$357K -39,934 -4%
Northern Trust
13
Northern Trust
Illinois
$8.12M -$549K -61,511 -6%
Barclays
14
Barclays
United Kingdom
$8.09M -$427K -47,783 -5%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$7.92M -$586K -65,600 -7%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$5.02M -$405K -45,379 -7%
PAI
17
Palo Alto Investors
California
$3.56M +$56.3K +6,300 +2%
Morgan Stanley
18
Morgan Stanley
New York
$3.5M +$79.6K +8,907 +2%
Principal Financial Group
19
Principal Financial Group
Iowa
$2.92M +$206K +23,015 +7%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$2.61M +$1.7M +190,609 +182%
TCIM
21
TIAA CREF Investment Management
New York
$2.58M -$65.5K -7,339 -2%
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$2.53M -$9.31M -1,041,965 -78%
Geode Capital Management
23
Geode Capital Management
Massachusetts
$2.44M +$52.4K +5,867 +2%
GC
24
Guggenheim Capital
Illinois
$2.35M -$612K -68,539 -21%
BA
25
Bard Associates
Illinois
$2.25M -$29K -3,250 -1%

SPPI Hedge Fund Activity: Q4 2013 in Review

115 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2013, worth a combined $377M — up 0.82% from $374M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SPPI and 12 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 43 added.

The largest buyer was Royal Bank of Canada, adding an estimated $10.4M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.31M.

  • 115 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2013, down from 118 in Q3 2013.
  • Funds reported $377M of Spectrum Pharmaceuticals Inc stock for Q4 2013, up 0.82% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2013 and 15 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2013 was Royal Bank of Canada, an estimated $10.4M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2013 was D.E. Shaw & Co, an estimated $9.31M sold.

Based on aggregated 13F filings for Q4 2013.